‘Alzheimer’s breakthrough’ is really just a Big Pharma illusion
October 20, 2015 – Not a snowball’s chance in, well... you know. That’s what an ex-FDA official thought of Eli Lilly’s chances of getting the brain drug solanezumab (sola) approved after data started leaking out a few years back. I’ve told you before how sola was supposed to prevent amyloid plaques from forming on... Read More >


